NASDAQ:ALGN - Align Technology Stock Price, News, & Analysis

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday, April, 24th. The medical equipment provider reported $0.89 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.06. The medical equipment provider had revenue of $549 million for the quarter, compared to the consensus estimate of $532.16 million. Align Technology had a return on equity of 30.58% and a net margin of 18.10%. The firm's revenue for the quarter was up 25.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.17 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, July 24th 2019. View Earnings Estimates for Align Technology.

Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 24th. The company provided earnings per share guidance of $1.47-1.54 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.23. The company issued revenue guidance of $590-600 million, compared to the consensus revenue estimate of $591.82 million.Align Technology also updated its Q2 2019 guidance to $1.47-1.54 EPS.

15 Wall Street analysts have issued 12 month price targets for Align Technology's shares. Their forecasts range from $210.00 to $430.00. On average, they expect Align Technology's stock price to reach $340.6154 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price. View Analyst Price Targets for Align Technology.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Headlines about ALGN stock have been trending positive this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Align Technology earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days.

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Wound Management Technologies (WNDM), Establishment Labs (ESTA), RTI Surgical (RTIX) and Invacare (IVC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), Adobe (ADBE), Paypal (PYPL), Mastercard (MA), salesforce.com (CRM), Boeing (BA) and Visa (V).

Align Technology's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.05%), Renaissance Technologies LLC (2.82%), Viking Global Investors LP (2.24%), Wellington Management Group LLP (2.08%), FMR LLC (1.48%) and Geode Capital Management LLC (1.48%). Company insiders that own Align Technology stock include C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Janus Henderson Group PLC, Wellington Management Group LLP, Renaissance Technologies LLC, Artisan Partners Limited Partnership, Morgan Stanley, Victory Capital Management Inc. and First Trust Advisors LP. Company insiders that have sold Align Technology company stock in the last year include Christopher C Puco, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was bought by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Goldman Sachs Group Inc., BlackRock Inc., Redmile Group LLC, Geode Capital Management LLC, Frontier Capital Management Co. LLC, Factory Mutual Insurance Co. and Busey Wealth Management. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $310.54.

Align Technology has a market capitalization of $24.84 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]